|
US1011184A
(en)
|
1909-10-18 |
1911-12-12 |
Joseph H Godfrey |
Bottle-filling device.
|
|
US1009252A
(en)
|
1910-11-26 |
1911-11-21 |
Michael E Mallo |
Carbureter.
|
|
US1013709A
(en)
|
1911-05-22 |
1912-01-02 |
New Orleans Specialty Co |
Game apparatus.
|
|
US2304669A
(en)
|
1940-08-16 |
1942-12-08 |
Adams Roger |
Isolation of cannabidiol
|
|
JPS5430146A
(en)
|
1977-08-05 |
1979-03-06 |
Microbial Chem Res Found |
Novel anthracycline derivatives and their preparation
|
|
GB9726916D0
(en)
|
1997-12-19 |
1998-02-18 |
Danbiosyst Uk |
Nasal formulation
|
|
EP1071419B1
(en)
*
|
1998-04-21 |
2007-07-25 |
THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Cannabinoids as antioxidants and neuroprotectants
|
|
US6403126B1
(en)
|
1999-05-26 |
2002-06-11 |
Websar Innovations Inc. |
Cannabinoid extraction method
|
|
US6949582B1
(en)
|
1999-05-27 |
2005-09-27 |
Wallace Walter H |
Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment
|
|
IL136839A
(en)
|
2000-06-16 |
2006-12-10 |
Yissum Res Dev Co |
Pharmaceutical compositions comprising cannabidiol derivatives, and processes for the preparation of same
|
|
DE10051427C1
(de)
|
2000-10-17 |
2002-06-13 |
Adam Mueller |
Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte
|
|
DK1361864T3
(en)
|
2001-02-14 |
2014-03-03 |
Gw Pharma Ltd |
FLYLDENDE SPRAY FORMULATIONS FOR buccal administration of cannabinoids
|
|
GB2377633A
(en)
|
2001-05-11 |
2003-01-22 |
Gw Pharmaceuticals Ltd |
Pharmaceutical compositions comprising the cannabinoids THC and CBD
|
|
US7025992B2
(en)
|
2001-02-14 |
2006-04-11 |
Gw Pharma Limited |
Pharmaceutical formulations
|
|
GB2381194A
(en)
|
2001-09-07 |
2003-04-30 |
Gw Pharmaceuticals Ltd |
Pharmaceutical formulations
|
|
GB2380129B
(en)
|
2001-02-14 |
2004-08-11 |
Gw Pharma Ltd |
Pharmaceutical formulations
|
|
GB2377218A
(en)
|
2001-05-04 |
2003-01-08 |
Gw Pharmaceuticals Ltd |
Process and apparatus for extraction of active substances and enriched extracts from natural products
|
|
GB2381450B
(en)
|
2001-10-31 |
2006-05-31 |
Gw Pharma Ltd |
Compositions for administration of natural or synthetic cannabinoids by vaporisation
|
|
GB0202385D0
(en)
|
2002-02-01 |
2002-03-20 |
Gw Pharma Ltd |
Compositions for the treatment of nausea,vomiting,emesis,motion sicknes or like conditions
|
|
ITPD20020138A1
(it)
|
2002-05-24 |
2003-11-24 |
Matteo Bevilacqua |
Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima.
|
|
DE10226494A1
(de)
|
2002-06-14 |
2004-01-08 |
Lts Lohmann Therapie-Systeme Ag |
Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen
|
|
US6946150B2
(en)
|
2002-08-14 |
2005-09-20 |
Gw Pharma Limited |
Pharmaceutical formulation
|
|
US10538373B2
(en)
|
2002-08-14 |
2020-01-21 |
Gw Pharma Limited |
Pharmaceutical formulation
|
|
MXPA05001621A
(es)
|
2002-08-14 |
2005-08-19 |
Gw Pharma Ltd |
Extraccion de cannabinoides farmaceuticamente activos de materiales vegetales.
|
|
EP1542657B8
(en)
|
2002-08-14 |
2012-03-14 |
GW Pharma Limited |
Cannabinoid liquid formulations for mucosal amdinistration
|
|
US6986748B2
(en)
|
2002-08-15 |
2006-01-17 |
Scimed Life Systems, Inc. |
Multiple biopsy apparatus and related method of use
|
|
GB0222077D0
(en)
|
2002-09-23 |
2002-10-30 |
Gw Pharma Ltd |
Methods of preparing cannabinoids from plant material
|
|
GB2393182B
(en)
|
2002-09-23 |
2007-03-14 |
Gw Pharma Ltd |
Method of preparing cannabidiol from plant material
|
|
US20040110828A1
(en)
|
2002-11-27 |
2004-06-10 |
Chowdhury Dipak K. |
Tetrahydrocannabinol compositions and methods of manufacture and use thereof
|
|
WO2005065069A2
(en)
|
2003-07-11 |
2005-07-21 |
Myriad Genetics, Inc. |
Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
|
|
IL160420A0
(en)
|
2004-02-16 |
2004-07-25 |
Yissum Res Dev Co |
Treating or preventing diabetes with cannabidiol
|
|
GB2414933B
(en)
|
2004-06-08 |
2009-07-15 |
Gw Pharma Ltd |
Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis
|
|
WO2006017892A1
(en)
|
2004-08-16 |
2006-02-23 |
Northern Sydney And Central Coast Area Health Service |
Methods for improving cognitive functioning
|
|
US9168278B2
(en)
|
2004-11-16 |
2015-10-27 |
Gw Pharma Limited |
Use for cannabinoid
|
|
GB0425248D0
(en)
|
2004-11-16 |
2004-12-15 |
Gw Pharma Ltd |
New use for cannabinoid
|
|
TWI366460B
(en)
|
2005-06-16 |
2012-06-21 |
Euro Celtique Sa |
Cannabinoid active pharmaceutical ingredient for improved dosage forms
|
|
US20070060638A1
(en)
|
2005-08-26 |
2007-03-15 |
Olmstead Mary C |
Methods and therapies for potentiating therapeutic activities of a cannabinoid receptor agonist via administration of a cannabinoid receptor antagonist
|
|
WO2007032962A2
(en)
|
2005-09-09 |
2007-03-22 |
University Of Kentucky |
Compositions and methods for intranasal delivery of tricyclic cannabinoids
|
|
EP2578561A1
(en)
|
2005-09-29 |
2013-04-10 |
Albany Molecular Research, Inc. |
Processes for the production of cannabidiol derivatives and intermediates thereof
|
|
GB2432312A
(en)
|
2005-11-01 |
2007-05-23 |
Gw Pharma Ltd |
Pharmaceutical compositions for the treatment of pain
|
|
GB2434312B
(en)
|
2006-01-18 |
2011-06-29 |
Gw Pharma Ltd |
Cannabinoid-containing plant extracts as neuroprotective agents
|
|
WO2007142957A2
(en)
|
2006-05-30 |
2007-12-13 |
Air Systems |
Gear drive damper
|
|
GB2438682A
(en)
|
2006-06-01 |
2007-12-05 |
Gw Pharma Ltd |
New use for cannabinoids
|
|
US20080112895A1
(en)
|
2006-08-04 |
2008-05-15 |
Insys Therapeutics Inc. |
Aqueous dronabinol formulations
|
|
WO2008021394A2
(en)
|
2006-08-15 |
2008-02-21 |
Theraquest Biosciences, Llc |
Pharmaceutical formulations of cannabinoids and method of use
|
|
US20110150825A1
(en)
|
2006-11-14 |
2011-06-23 |
Pharmacyclics, Inc. |
Uses of selective inhibitors of hdac8 for treatment of inflammatory conditions
|
|
US20080188461A1
(en)
|
2007-02-01 |
2008-08-07 |
Regents Of The University Of Michigan |
Compositions and methods for detecting, preventing and treating seizures and seizure related disorders
|
|
CN101040855A
(zh)
|
2007-04-12 |
2007-09-26 |
杨喜鸿 |
含有利莫那班和泊洛沙姆的组合物、固体分散体及其制备和药物应用
|
|
GB2448535A
(en)
|
2007-04-19 |
2008-10-22 |
Gw Pharma Ltd |
New use for cannabinoid-containing plant extracts
|
|
WO2008144475A1
(en)
|
2007-05-17 |
2008-11-27 |
California Pacific Medical Center |
Methods and compositions for treating cancer
|
|
GB2449691A
(en)
|
2007-05-31 |
2008-12-03 |
Gw Pharma Ltd |
A reference plant lacking medicinal active compound expression
|
|
EP2023121A1
(en)
|
2007-07-06 |
2009-02-11 |
Bp Oil International Limited |
Optical cell
|
|
GB2450753B
(en)
|
2007-07-06 |
2012-07-18 |
Gw Pharma Ltd |
New Pharmaceutical formulation
|
|
DK2176208T3
(en)
*
|
2007-07-30 |
2015-04-27 |
Zynerba Pharmaceuticals Inc |
Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof
|
|
WO2009020666A1
(en)
|
2007-08-06 |
2009-02-12 |
Insys Therapeutics Inc. |
Oral cannabinoid liquid formulations and methods of treatment
|
|
US8222292B2
(en)
|
2007-08-06 |
2012-07-17 |
Insys Therapeutics, Inc. |
Liquid cannabinoid formulations
|
|
GB2456183A
(en)
|
2008-01-04 |
2009-07-08 |
Gw Pharma Ltd |
Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament
|
|
GB2459637B
(en)
|
2008-01-21 |
2012-06-06 |
Gw Pharma Ltd |
New use for cannabinoids
|
|
US9023322B2
(en)
|
2008-03-26 |
2015-05-05 |
Stichting Sanammad |
Chewing gum compositions comprising cannabinoids
|
|
GB2478072B
(en)
|
2008-06-04 |
2012-12-26 |
Gw Pharma Ltd |
Anti-tumoural effects of cannabinoid combinations
|
|
GB2471987B
(en)
|
2008-06-04 |
2012-02-22 |
Gw Pharma Ltd |
Anti-tumoural effects of cannabinoid combinations
|
|
GB2475183B
(en)
|
2008-06-04 |
2011-11-23 |
Gw Pharma Ltd |
Cannabinoids in combination with non-cannabinoid chemotherapeutic agent that are selective estrogen receptor modulators
|
|
GB2478074B
(en)
|
2008-06-04 |
2012-12-26 |
Gw Pharma Ltd |
Anti-tumoural effects of cannabinoid combinations
|
|
US20110257256A1
(en)
|
2008-07-31 |
2011-10-20 |
Bionoria Research Gmbh |
Cannabinoids for use in treating or preventing cognitive impairment and dementia
|
|
WO2010031054A1
(en)
|
2008-09-15 |
2010-03-18 |
Biovista, Inc. |
Compositions and methods for treating epilepsy
|
|
US8809261B2
(en)
|
2008-10-31 |
2014-08-19 |
Elsohly Laboratories, Incorporated |
Compositions containing delta-9-THC-amino acid esters and process of preparation
|
|
WO2010127033A1
(en)
|
2009-04-28 |
2010-11-04 |
Alltranz Inc. |
Formulations of cannabidiol and methods of using the same
|
|
EP2424568A1
(en)
|
2009-04-29 |
2012-03-07 |
University Of Kentucky Research Foundation |
Cannabinoid-containing compositions and methods for their use
|
|
ES2409055T3
(es)
|
2009-06-29 |
2013-06-24 |
Bender Analytical Holding B.V. |
Sistema de suministro de fármacos que comprende polioxazolina y un agente bioactivo
|
|
GB2471523A
(en)
|
2009-07-03 |
2011-01-05 |
Gw Pharma Ltd |
Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy
|
|
US8735374B2
(en)
|
2009-07-31 |
2014-05-27 |
Intelgenx Corp. |
Oral mucoadhesive dosage form
|
|
US20110033529A1
(en)
|
2009-08-06 |
2011-02-10 |
Durga Prasad Samantaray |
Oral pharmaceutical paricalcitol formulations
|
|
JP2013505248A
(ja)
|
2009-09-16 |
2013-02-14 |
アラーガン インコーポレイテッド |
発作性疾患を治療するための組成物及び方法
|
|
GB2478595B
(en)
|
2010-03-12 |
2018-04-04 |
Gw Pharma Ltd |
Phytocannabinoids in the treatment of glioma
|
|
GB2487183B
(en)
|
2011-01-04 |
2018-10-03 |
Otsuka Pharma Co Ltd |
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy
|
|
TWI583374B
(zh)
|
2010-03-30 |
2017-05-21 |
Ｇｗ伐瑪有限公司 |
使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途
|
|
GB2479153B
(en)
|
2010-03-30 |
2014-03-19 |
Gw Pharma Ltd |
The phytocannabinoid cannabidivarin (CBDV) for use in the treatment of epilepsy
|
|
AU2011264941B2
(en)
|
2010-06-07 |
2014-10-16 |
Suda Ltd |
Oral spray formulations and methods for administration of sildenafil
|
|
EP3459533A1
(en)
|
2010-08-04 |
2019-03-27 |
Grünenthal GmbH |
Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain
|
|
WO2012033478A1
(en)
|
2010-09-07 |
2012-03-15 |
Murty Pharmaceuticals, Inc. |
An improved oral dosage form of tetrahydrocannabinol and a method of avoiding and/or suppressing hepatic first pass metabolism via targeted chylomicron/lipoprotein delivery
|
|
US8895537B2
(en)
|
2010-10-29 |
2014-11-25 |
Infirst Healthcare Ltd. |
Compositions and methods for treating cardiovascular diseases
|
|
GB2487712B
(en)
*
|
2011-01-04 |
2015-10-28 |
Otsuka Pharma Co Ltd |
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
|
|
CA2737447A1
(en)
|
2011-04-27 |
2012-10-27 |
Antony Paul Hornby |
Hayley's comet
|
|
US9104993B2
(en)
|
2011-04-28 |
2015-08-11 |
Lantronix, Inc. |
Asset management via virtual tunnels
|
|
GB2491118B
(en)
|
2011-05-20 |
2015-12-30 |
Otsuka Pharma Co Ltd |
Cannabinoids for use in the treatment of neuropathic pain
|
|
GB201111261D0
(en)
|
2011-07-01 |
2011-08-17 |
Gw Pharma Ltd |
Cannabinoids for use in the treatment of neuro-degenerative diseases or disorders
|
|
US8808734B2
(en)
|
2011-07-11 |
2014-08-19 |
Full Spectrum Laboratories Limited |
Cannabinoid formulations
|
|
EP2747770A1
(en)
|
2011-08-26 |
2014-07-02 |
BIAL - Portela & Cª S.A. |
Treatments involving eslicarbazepine acetate or eslicarbazepine
|
|
GB2495118B
(en)
|
2011-09-29 |
2016-05-18 |
Otsuka Pharma Co Ltd |
A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
|
|
GB2496687A
(en)
|
2011-11-21 |
2013-05-22 |
Gw Pharma Ltd |
Tetrahydrocannabivarin (THCV) in the protection of pancreatic islet cells
|
|
US9254272B2
(en)
|
2011-11-30 |
2016-02-09 |
Sutter West Bay Hospitals |
Resorcinol derivatives
|
|
GB2504263B
(en)
|
2012-06-08 |
2015-09-16 |
Gw Pharma Ltd |
Synergistic therapies for neuroprotection
|
|
DE102012105063C5
(de)
|
2012-06-12 |
2023-09-14 |
Thc Pharm Gmbh The Health Concept |
Stabilisierung von Cannabinoiden und deren pharmazeutischen Zubereitungen
|
|
US9345771B2
(en)
|
2012-10-04 |
2016-05-24 |
Insys Development Company, Inc. |
Oral cannabinoid formulations
|
|
AU2014206036B2
(en)
|
2013-01-08 |
2017-11-02 |
Universidade De Sao Paulo - Usp |
Fluorinated CBD compounds, compositions and uses thereof
|
|
CN103110582A
(zh)
|
2013-03-04 |
2013-05-22 |
上海医药工业研究院 |
大麻酚类化合物微乳剂及其制备方法
|
|
WO2014145490A2
(en)
|
2013-03-15 |
2014-09-18 |
Biotech Institute, Llc |
Breeding, production, processing and use of specialty cannabis
|
|
LT2976074T
(lt)
|
2013-03-19 |
2020-03-25 |
Universitat Pompeu-Fabra |
Kanabinoido receptoriaus cb1 antagonistai, skirti naudoti gydant ligas, susijusias su neuronų dendritų anomalijomis
|
|
JP6300613B2
(ja)
|
2013-04-09 |
2018-03-28 |
キヤノン株式会社 |
トナー用樹脂およびトナー
|
|
US9549909B2
(en)
|
2013-05-03 |
2017-01-24 |
The Katholieke Universiteit Leuven |
Method for the treatment of dravet syndrome
|
|
GB2516814B
(en)
|
2013-06-19 |
2016-08-31 |
Otsuka Pharma Co Ltd |
Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
|
|
GB2515312A
(en)
|
2013-06-19 |
2014-12-24 |
Gw Pharma Ltd |
The use of phytocannabinoids in the treatment of ovarian carcinoma
|
|
US20150181924A1
(en)
|
2013-10-31 |
2015-07-02 |
Michael R. Llamas |
Cannabidiol liquid composition for smoking
|
|
US9259449B2
(en)
|
2014-01-07 |
2016-02-16 |
Joshua Michael Raderman |
Method for modifying THC content in a lipid-based extract of cannabis
|
|
US10052339B2
(en)
|
2014-03-21 |
2018-08-21 |
Bodybio Inc. |
Methods and compositions for treating symptoms of diseases related to imbalance of essential fatty acids
|
|
CN103913888B
(zh)
|
2014-03-28 |
2016-08-17 |
京东方科技集团股份有限公司 |
一种彩膜基板、显示装置及彩膜基板的制造方法
|
|
US11331279B2
(en)
|
2014-05-29 |
2022-05-17 |
Radius Pharmaceuticals, Inc. |
Stable cannabinoid formulations
|
|
US12544389B2
(en)
|
2014-05-29 |
2026-02-10 |
Fresh Cut Development, Llc |
Stable cannabinoid formulations
|
|
CA2950424C
(en)
|
2014-05-29 |
2023-03-14 |
Insys Pharma, Inc. |
Stable cannabinoid formulations
|
|
US11911361B2
(en)
|
2014-05-29 |
2024-02-27 |
Radius Pharmaceuticals, Inc. |
Stable cannabinoid formulations
|
|
WO2015187988A1
(en)
|
2014-06-04 |
2015-12-10 |
Intellimedix |
Composition and methods of treating epilepsy and/or epilepsy-related disorders
|
|
GB2530001B
(en)
|
2014-06-17 |
2019-01-16 |
Gw Pharma Ltd |
Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
|
|
GB2527591A
(en)
|
2014-06-27 |
2015-12-30 |
Gw Pharma Ltd |
7-hydroxy cannabidiol (7-OH-CBD) for use in the treatment of non-alcoholic fatty liver disease (NAFLD)
|
|
GB2527590A
(en)
|
2014-06-27 |
2015-12-30 |
Otsuka Pharma Co Ltd |
Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer
|
|
GB2527599A
(en)
|
2014-06-27 |
2015-12-30 |
Gw Pharma Ltd |
Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy
|
|
WO2016010827A1
(en)
|
2014-07-14 |
2016-01-21 |
Librede Inc. |
Production of cannabinoids in yeast
|
|
US9492438B2
(en)
|
2014-07-25 |
2016-11-15 |
Bette Pollard |
Amphiphilic pyridinum compounds to treat epilepsy and other disorders of the nervous system
|
|
WO2016022936A1
(en)
|
2014-08-07 |
2016-02-11 |
Murty Pharmaceuticals, Inc. |
An improved oral gastrointestinal dosage form delivery system of cannabinoids and/or standardized marijuana extracts
|
|
CA2859934A1
(en)
|
2014-09-22 |
2016-03-22 |
A. Paul Hornby |
Hayley's comet ii
|
|
GB2531283A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiols in the treatment of degenerative skeletal muscle diseases
|
|
GB2531280A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
GB2531282A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2531278A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
GB2531281A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
MX2017005277A
(es)
|
2014-10-21 |
2018-01-11 |
United Cannabis Corp |
Extractos de cannabis y métodos de preparación y uso de la misma.
|
|
CN104490873A
(zh)
|
2014-11-25 |
2015-04-08 |
邹丽萍 |
一种治疗儿童结节性硬化症的药物
|
|
CA2968929A1
(en)
|
2014-11-26 |
2016-06-02 |
One World Cannabis Ltd |
Synergistic use of cannabis for treating multiple myeloma
|
|
US9622145B2
(en)
|
2014-12-05 |
2017-04-11 |
At&T Intellectual Property I, L.P. |
Wireless network architecture for providing media content
|
|
US10172786B2
(en)
|
2014-12-16 |
2019-01-08 |
Axim Biotechnologies, Inc. |
Oral care composition comprising cannabinoids
|
|
US10751300B2
(en)
|
2015-01-25 |
2020-08-25 |
India Globalization Capital, Inc. |
Composition and method for treating seizure disorders
|
|
BR112017018944A2
(en)
|
2015-03-02 |
2018-05-15 |
Afgin Pharma, Llc |
method of treating a disease state or condition in humans with a carbinoid drug, and method of treating a disease state or condition in a mammal other than a human with carbinoid drug (s)
|
|
US20160338974A1
(en)
|
2015-03-02 |
2016-11-24 |
Afgin Pharma, Llc |
Topical regional neuro affective therapy with cannabinoid combination products
|
|
US10354246B1
(en)
|
2015-03-18 |
2019-07-16 |
Square, Inc. |
Cash transaction machine
|
|
EP3270896A4
(en)
|
2015-03-19 |
2018-09-12 |
One World Cannabis Ltd. |
Preparations of cannabis emulsions and methods thereof
|
|
US20160317468A1
(en)
|
2015-04-28 |
2016-11-03 |
Raman Sankar |
Uses of cannabidiol for treatment of infantile spasms
|
|
US10450302B2
(en)
|
2015-05-11 |
2019-10-22 |
Lundbeck La Jolla Research Center, Inc. |
Methods of treating inflammation or neuropathic pain
|
|
DK3302437T4
(da)
|
2015-05-28 |
2026-02-23 |
Fresh Cut Dev Llc |
Stabile cannabinoidformuleringer
|
|
WO2017203529A1
(en)
|
2016-05-24 |
2017-11-30 |
Bol Pharma Ltd. |
Compositions comprising cannabidiol and hyaluronic acid for treating inflammatory joint diseases
|
|
WO2016199148A1
(en)
|
2015-06-11 |
2016-12-15 |
One World Cannabis Ltd |
Novel cannabinoid combination therapies for multiple myeloma (mm)
|
|
GB2539472A
(en)
|
2015-06-17 |
2016-12-21 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
US20170008869A1
(en)
|
2015-07-10 |
2017-01-12 |
Noramco, Inc. |
Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
|
|
GB2541191A
(en)
|
2015-08-10 |
2017-02-15 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2542155B
(en)
|
2015-09-09 |
2018-08-01 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of mental disorders
|
|
GB2542797A
(en)
|
2015-09-29 |
2017-04-05 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of inflammatory skin diseases
|
|
JP6676176B2
(ja)
|
2016-01-29 |
2020-04-08 |
ユニヴァーシティー オブ ミシシッピ |
生物学的に活性なカンナビジオール類似体
|
|
WO2017139496A1
(en)
|
2016-02-09 |
2017-08-17 |
Cevolva Biotech, Inc. |
Microbial engineering for the production of cannabinoids and cannabinoid precursors
|
|
GB2548873B
(en)
|
2016-03-31 |
2020-12-02 |
Gw Res Ltd |
Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
|
|
EP3462885B1
(en)
|
2016-05-27 |
2026-07-15 |
Fresh Cut Development, LLC |
Pharmaceutical formulation comprising cannabidiol and caprylic/capric triglyceride for use in the treatment of a disease or disorder
|
|
GB2551987A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2551986A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Parenteral formulations
|
|
GB2551985B
(en)
|
2016-07-01 |
2019-01-30 |
Gw Res Ltd |
Novel formulation
|
|
IL246790A0
(en)
|
2016-07-14 |
2016-09-29 |
Friedman Doron |
Self-dissolving compounds of cannabinoids
|
|
GB2553139A
(en)
|
2016-08-25 |
2018-02-28 |
Gw Res Ltd |
Use of cannabinoids in the treatment of multiple myeloma
|
|
GB2557921A
(en)
|
2016-12-16 |
2018-07-04 |
Gw Res Ltd |
Use of cannabinoids in the treatment of angelman syndrome
|
|
US20200215022A1
(en)
|
2016-12-20 |
2020-07-09 |
Tilray, Inc. |
Novel cannabinoid compositions and methods of treating pediatric epilepsy
|
|
CN108236608B
(zh)
|
2016-12-27 |
2020-05-08 |
汉义生物科技（北京）有限公司 |
大麻二酚与氨己烯酸的药物组合物及其用途
|
|
GB2559774B
(en)
|
2017-02-17 |
2021-09-29 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2560019A
(en)
|
2017-02-27 |
2018-08-29 |
Gw Res Ltd |
Use of cannabinoids in the treatment of leukaemia
|
|
JP2020517727A
(ja)
|
2017-04-27 |
2020-06-18 |
インシス・ディベロップメント・カンパニー・インコーポレイテッド |
安定なカンナビノイド製剤
|
|
GB2564383B
(en)
|
2017-06-23 |
2021-04-21 |
Gw Res Ltd |
Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex
|
|
IT201700085508A1
(it)
|
2017-07-26 |
2019-01-26 |
Inalco S R L |
Metodo per la produzione di cannabinoidi da varietà di canapa industriale
|
|
US10925525B2
(en)
|
2017-08-18 |
2021-02-23 |
Canon U.S.A., Inc. |
Combined pulse oximetry and diffusing wave spectroscopy system and control method therefor
|
|
GB201715919D0
(en)
|
2017-09-29 |
2017-11-15 |
Gw Res Ltd |
use of cannabinoids in the treatment of epilepsy
|
|
GB2568471B
(en)
|
2017-11-15 |
2022-04-13 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
WO2019100172A1
(en)
|
2017-11-27 |
2019-05-31 |
Beleave Inc. |
Extraction and purification of cannabinoid compounds
|
|
GB2568929A
(en)
|
2017-12-01 |
2019-06-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
EP3732813A1
(en)
|
2017-12-29 |
2020-11-04 |
Telefonaktiebolaget LM Ericsson (publ) |
Methods providing transmission and/or searching of encrypted data and related devices
|
|
GB2569961B
(en)
|
2018-01-03 |
2021-12-22 |
Gw Res Ltd |
Pharmaceutical
|
|
GB2572126B
(en)
|
2018-01-03 |
2021-01-13 |
Gw Res Ltd |
Pharmaceutical
|
|
GB2572125B
(en)
|
2018-01-03 |
2021-01-13 |
Gw Res Ltd |
Pharmaceutical
|
|
GB2572737A
(en)
|
2018-01-24 |
2019-10-16 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB201806953D0
(en)
|
2018-04-27 |
2018-06-13 |
Gw Res Ltd |
Cannabidiol Preparations
|
|
WO2019210210A1
(en)
|
2018-04-27 |
2019-10-31 |
Thomas Jefferson University |
Nanospun hemp-based materials
|
|
WO2019211795A1
(en)
|
2018-05-03 |
2019-11-07 |
Radient Technologies Inc. |
Continuous flow microwave-assisted extraction of a cannabis biomass
|
|
ES2987796T3
(es)
|
2018-10-30 |
2024-11-18 |
Gilead Sciences Inc |
Derivados de N-benzoil-fenilalanina como inhibidores de la integrina alfa4beta7 para el tratamiento de enfermedades inflamatorias
|
|
GB2579179A
(en)
|
2018-11-21 |
2020-06-17 |
Gw Res Ltd |
Cannabidiol-type cannabinoid compound
|
|
GB2580881A
(en)
|
2018-11-30 |
2020-08-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2580653A
(en)
|
2019-01-21 |
2020-07-29 |
Gw Res Ltd |
Use of cannabinoids in the treatment of comorbidities associated with epilepsy
|
|
GB2581517A
(en)
|
2019-02-22 |
2020-08-26 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2581987B
(en)
|
2019-03-06 |
2021-11-17 |
Gw Res Ltd |
Use of cannabidiol in combination with antibiotics
|
|
GB2583526A
(en)
|
2019-05-03 |
2020-11-04 |
Gw Res Ltd |
Use of cannabidiol in the treatment of tuberous sclerosis complex
|
|
GB2584140A
(en)
|
2019-05-23 |
2020-11-25 |
Gw Res Ltd |
Use of cannabidiol in the treatment of epileptic spasms
|
|
GB2584341B
(en)
|
2019-05-31 |
2023-03-01 |
Gw Res Ltd |
Cannabinoid formulations
|
|
CN110215443A
(zh)
|
2019-07-08 |
2019-09-10 |
云南绿新生物药业有限公司 |
一种抗衰老、改善睡眠软胶囊的制备方法
|
|
GB201910389D0
(en)
|
2019-07-19 |
2019-09-04 |
Gw Pharma Ltd |
Novel compounds, methods for their manufacture, and uses thereof
|
|
GB2586026A
(en)
|
2019-07-29 |
2021-02-03 |
Gw Res Ltd |
Use of cannabidol in the treatment of Dravet syndrome
|
|
CN110279617A
(zh)
|
2019-08-05 |
2019-09-27 |
云南绿新生物药业有限公司 |
一种含火麻精油的洗发水及其制备方法
|
|
GB2588576A
(en)
|
2019-08-27 |
2021-05-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of dyskinesia associated with Parkinson's disease
|
|
GB2589306A
(en)
|
2019-10-25 |
2021-06-02 |
Gw Res Ltd |
Use of cannabidiol preparations in the treatment of fragile X syndrome
|
|
GB2588457B
(en)
|
2019-10-25 |
2022-12-21 |
Gw Res Ltd |
Cannabinoid compound
|
|
GB2588461A
(en)
|
2019-10-25 |
2021-04-28 |
Gw Res Ltd |
Use of cannabidiol preparations in the treatment of absence epilepsy
|
|
GB2588460A
(en)
|
2019-10-25 |
2021-04-28 |
Gw Res Ltd |
Use of cannabidiol preparations in the treatment of temporal lobe epilepsy
|
|
GB201916846D0
(en)
|
2019-11-19 |
2020-01-01 |
Gw Res Ltd |
Cannabidiol-type cannabinoid compound
|
|
GB201916849D0
(en)
|
2019-11-19 |
2020-01-01 |
Gw Res Ltd |
Cannabidiol-type cannabinoid compound
|
|
GB201916974D0
(en)
|
2019-11-21 |
2020-01-08 |
Gw Res Ltd |
Cannabidol-type cannabinoid compound
|
|
GB201916977D0
(en)
|
2019-11-21 |
2020-01-08 |
Gw Res Ltd |
Cannibidol-type cannabinoid compound
|
|
GB201918846D0
(en)
|
2019-12-19 |
2020-02-05 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB202002754D0
(en)
|
2020-02-27 |
2020-04-15 |
Gw Res Ltd |
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
|
|
US11409517B2
(en)
|
2020-06-08 |
2022-08-09 |
Microsoft Technology Licensing, Llc |
Intelligent prefetching for OS components
|
|
GB202009321D0
(en)
|
2020-06-18 |
2020-08-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2597312A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597323A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2600077A
(en)
|
2020-07-20 |
2022-04-27 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597309A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597322A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597306A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597318A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597308A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
|
|
GB2597317A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597313A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597311A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597285A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597321A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597315A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597281A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury
|
|
GB2597316A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB202013765D0
(en)
|
2020-09-02 |
2020-10-14 |
Gw Res Ltd |
Method of preparing cannabinoids
|
|
GB202014250D0
(en)
|
2020-09-10 |
2020-10-28 |
Gw Res Ltd |
Use of cannabidivarin in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2598922A
(en)
|
2020-09-18 |
2022-03-23 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
US20220087951A1
(en)
|
2020-09-18 |
2022-03-24 |
GW Research Limited |
Use of cannabinoids in the treatment of epilepsy
|
|
US11160757B1
(en)
|
2020-10-12 |
2021-11-02 |
GW Research Limited |
pH dependent release coated microparticle cannabinoid formulations
|
|
GB2601755A
(en)
|
2020-12-08 |
2022-06-15 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with epilepsy syndromes
|
|
GB2602020A
(en)
|
2020-12-15 |
2022-06-22 |
Gw Res Ltd |
A method for evaluating the pro- or anti convulsive properties of test compounds
|
|
GB2602019A
(en)
|
2020-12-15 |
2022-06-22 |
Gw Res Ltd |
Cannabinoid derivative as a pharmaceutically active compound and method of preparation thereof
|
|
TW202237554A
(zh)
|
2020-12-15 |
2022-10-01 |
英商吉偉研究有限公司 |
新穎化合物、其製備方法及其用途
|
|
GB2606334A
(en)
|
2021-02-12 |
2022-11-09 |
Gw Res Ltd |
Use of cannabidivarin in the treatment of seizures associated with canine epilepsy
|
|
CA3216180A1
(en)
|
2021-05-12 |
2022-11-17 |
GW Research Limited |
6-hydroxy-cannabidiol-c4
|
|
CA3218211A1
(en)
|
2021-05-12 |
2022-11-17 |
Alan James SILCOCK |
Resorcinol derivative as a pharmaceutically active compound and method of preparation thereof
|
|
JP2024517326A
(ja)
|
2021-05-12 |
2024-04-19 |
ジーダブリュー・リサーチ・リミテッド |
レゾルシノール類、それら製造のための方法、及びその使用
|
|
CA3216179A1
(en)
|
2021-05-12 |
2022-11-17 |
Alan James SILCOCK |
Derivatives of cannabidiol-c4 for the treatment of epilepsy
|
|
EP4376820A1
(en)
|
2021-07-28 |
2024-06-05 |
GW Research Limited |
Use of cannabidiol in the treatment of epilepsy
|
|
US11815187B2
(en)
|
2022-01-26 |
2023-11-14 |
Maag Germany Gmbh |
3-port valve
|